Nm23 expression in retinoblastoma

Ocular Immunology and Inflammation

Volumn 12, Issue 2, 2004, Pages 127-135

  Krishnakumar, Subramanian ^a   Lakshmi, Amirtha ^a   Shanmugam, Mahesh P ^a   Vanitha, K ^a   Biswas, Jyotirmay ^a  

^a MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

Differentiation; Invasion; Metastasis suppressor protein; Prognosis; Retinoblastoma

Indexed keywords

PROTEIN NM 23; SUPPRESSOR FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CHOROID; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OPTIC NERVE; ORBIT; PROGNOSIS; PROTEIN EXPRESSION; RETINOBLASTOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NUCLEOSIDE-DIPHOSPHATE KINASE; RETINAL NEOPLASMS; RETINOBLASTOMA; STAINING AND LABELING;

EID: 4243135933     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1080/09273940490895335     Document Type: Article

References (19)

1. Donaldson SS, Smith LM. Retinoblastoma: biology, presentation, and current management. Oncology. 1989;3:45-51; discussion 51-52.
2. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371-377.
3. Finger PT, Harbour W, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47:1-16.
4. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst. 2000;92:1717-1730.
5. Lombardi D, Lacombe ML, Paggi MG. Nm23: unraveling its biological function in cell differentiation. J Cell Physiol. 2000;182:144-149.
6. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathological analysis of 232 eyes with retinoblastoma, conducted in an Indian tertiary ophthalmic care center. J Pediatr Ophthalmol Strabismus. [In press] 2003.
7. Ayhan A, Yasui W, Yokosaki H, Kitadai Y, Tahara E. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastasis in human colorectal carcinomas. Virchows Arch Pathol. 1993;63:213-218.
8. Bardak Y, Cekic O, Ayhan A, Gunlap I, Bulay O. nm23 expression in choroidal melanoma. Ophthalmic Res. 2000;32:257-260.
9. Gilles AM, Preseccan E, Vonica A, Lascus I. Nucleoside diphosphate from human erythrocytes: structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991;226:8784-8789.
10. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC. Prognostic value of nm23 expression in stage IB 1 cervical carcinoma. Jpn J Clin Oncol. 2001;31:327-332.
11. Mao H, Liu H, Fu X, Fang Z, Abrams J, Worsham MJ. Loss of nm23 expression predicts distal metastases and poor survival for breast cancer. Int J Oncol. 2001;18:587-591.
12. Yamaguchi A, Urano T, Goi T, Takeuchi, K Niimoto S, Nakagawara G, Furukawa K, Shiku H. Expression of human nm23 H1 and nm23 H2 proteins in hepatocellular carcinoma. Cancer. 1994;73:2280-2284.
13. Scambia G, Ferrandina G, Marone M, Benedetti Panici P, Giannitelli C, Piantelli M, Leone A, Mancuso S. Nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol. 1996;14:334-342.
14. Watanabe J, Sato Y, Kuramoto H, Tameya T. Expression of nm23 H1 and nm23 H2 protein in endometrial carcinoma. Br J Cancer. 1995;72:1469-1473
15. Nakayama H, Yasui W, Yokozaki H, Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res. 1993;84:184-190.
16. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991;88:341-345.
17. Aryee DN, Simonitsch I, Mosberger I, Kos K, Mann G, Schlögl E, Pötschger U, Gadner H, Radaszkiewicz T, Kovar H. Variability of nm23 H1/NDPK-A expression in human lymphomas and its relation to tumor aggressiveness. Br J Cancer. 1996;74:1693-1698.
18. Okabe-Kado J, Kasukabe T, Honma Y. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia. Leuk Lymphoma. 1998;32:19-28.
19. Lombardi D, Palescandolo E, Giordano A, Paggi MG. Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC 12 cells. Cell Death Differ. 2001;8:470-476.